Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Corveus Medical
AddedMar 20, 2024
UpdatedJul 3, 2026
Corveus Medical

Corveus Medical

Pre-Seed

Corveus Medical: Innovating catheter-based nerve ablation for heart failure treatment.

HQ
Houston, TX, US
Founded
2021
Accelerator
Y Combinator logoY CombinatorW22
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize heart failure treatment, Corveus Medical focuses on developing innovative catheter-based solutions. Their core product is a device designed for targeted nerve ablation in the upper abdomen, addressing the concerns of cardiologists regarding collateral tissue damage. By ensuring precise targeting and confirmation of correct procedure execution, Corveus Medical aims to enhance the safety and efficacy of heart failure treatments.

Corveus Medical has garnered attention from notable figures in the medical and investment communities, contributing to its rapid growth and development. The company has achieved significant milestones in clinical trials, demonstrating the effectiveness and safety of their device. Through their cutting-edge technology, Corveus Medical is making a substantial impact on the treatment landscape for chronic heart failure, offering new hope to patients and healthcare providers alike.

Corveus Medical - Similar Companies

CoraVie Medical logo

CoraVie Medical

coraviemedical.com

Corinnova logo

Corinnova

corinnova.com

Procyrion logo

Procyrion

Capstan Medical logo

Capstan Medical

capstanmedical.com

Corisma MCS Systems logo

Corisma MCS Systems

corismacv.com

Corfigo logo

Corfigo

corfigo.com

Cvrx logo

Cvrx

cvrx.com

East End Medical logo

East End Medical

Field Medical logo

Field Medical

Cormedics logo

Cormedics

cormedicscorp.com

Vena Medical logo

Vena Medical

venamed.ca

Viacor logo

Viacor

Ablative Solutions logo

Ablative Solutions

V-Flow Medical logo

V-Flow Medical

Conformal Medical logo

Conformal Medical

Corveus Medical - Quick Facts

Who are Corveus Medical's competitors?

Companies similar to Corveus Medical include CoraVie Medical, Corinnova, Procyrion and Capstan Medical.

When was Corveus Medical founded?

Corveus Medical was founded in 2021.

Where is Corveus Medical's headquarters located?

Corveus Medical's headquarters is located in Houston, TX, US.

How much has Corveus Medical raised to-date?

As of Jul 26, 2023, Corveus Medical has raised a total of $500k (USD).

How many employees does Corveus Medical have?

Corveus Medical has 3 employees as of Aug 23, 2023.

Corveus Medical - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Robotics
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified